Transplanting hepatitis C virus–infected hearts into uninfected recipients: A single‐arm trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transplanting hepatitis C virus–infected hearts into uninfected recipients: A single‐arm trial
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-16
DOI
10.1111/ajt.15311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
- (2018) Christine M. Durand et al. ANNALS OF INTERNAL MEDICINE
- Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
- (2018) Nancy Reau et al. HEPATOLOGY
- Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies
- (2018) Kelly H. Schlendorf et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant
- (2018) Maureen McCauley et al. TRANSPLANTATION
- Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients
- (2018) Peter P. Reese et al. ANNALS OF INTERNAL MEDICINE
- Rational Heart Transplant From a Hepatitis C Donor: New Antiviral Weapons Conquer the Trojan Horse
- (2017) Robert L. Gottlieb et al. JOURNAL OF CARDIAC FAILURE
- Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
- (2017) David S. Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic
- (2016) D. S. Goldberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance
- (2016) Vincent Lo Re et al. Clinical Gastroenterology and Hepatology
- Perioperative Ledipasvir–Sofosbuvir for HCV in Liver-Transplant Recipients
- (2016) Josh Levitsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies
- (2015) M. Willicombe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Transplanting Hepatitis C–Positive Kidneys
- (2015) Peter P. Reese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- (2015) Graham R. Foster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
- (2015) Susanna Naggie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
- (2015) David L. Wyles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing
- (2012) Hui Li et al. PLoS Pathogens
- Peginterferon α-2b and Acute Allograft Failure in a Heart Transplant Recipient
- (2010) Bing-Yen Wang et al. ANNALS OF THORACIC SURGERY
- Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
- (2009) Maribel Rodriguez-Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
- (2008) Adrian M. Di Bisceglie et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started